Obesity Weekly News

Obesity Weekly News - July 8th 2025

China’s Dual GCG/GLP-1 Breakthrough, Innogen’s 2026 Goal, Zepbound's Korea…


Obesity Weekly News

Obesity Weekly News - July 1st 2025

Fractyl’s Gene Therapy Breakthrough, Verdiva’s Oral GLP-1 Pipeline, Viking’s…


Obesity Weekly News

Obesity Weekly News - June 24th 2025

Eccogene’s Oral GLP-1 Debut, Novo’s 24% Weight Loss Win, Lilly’s Q3 Reveal…


Obesity Weekly News

Obesity Weekly News - June 17th 2025

Obesity 🚨 Breakthroughs in Obesity Drug Development You Need to Know! In this…


Obesity Weekly News

Obesity Weekly News - June 10th 2025

Obesity Advancements: Arrowhead’s RNAi Debut, Lilly’s $870M Bet, Novo’s Triple…


Obesity Weekly News

Obesity Weekly News - June 3rd 2025

Obesity Advancements: Regeneron’s Triplet Breakthrough, $2B Hansoh Deal,…


Obesity Weekly News

Obesity Weekly News - May 27th 2025

Obesity Advancements: Ascletis’ Combo Trial, Mazdutide’s NEJM Breakthrough,…


Obesity Weekly News

Obesity Weekly News - May 20th 2025

Latest Obesity Updates: Zealand’s Obesity Strategy, $2.2B Novo Deal, China’s…


Obesity Weekly News

Obesity Weekly News - May 13th 2025

30% Weight Loss, Zepbound vs Wegovy & Affordable Semaglutide Deals In this…


Obesity Weekly News

Obesity Weekly News - May 6th 2025

Obesity Latest News: GLP-1 Pill Update, Discount Wars & Pharma Shakeups In…


Obesity Weekly News

Obesity Weekly News - April 29th 2025

GLP-1 Pills, Court Rulings & Obesity Market Shakeups In this week's…


Obesity Weekly News

Obesity Weekly News - April 22nd 2025

💊 Obesity Watch: GLP-1 Pills, Trial Updates & Global Market Moves  …


Privacy Preference Center